| Literature DB >> 29743940 |
Nayana Gunathilaka1, Miyuru Chandradasa2,3, Layani Champika3, Shirom Siriwardana4, Lakmini Wijesooriya5.
Abstract
BACKGROUND: Although the physical consequences of dengue are well documented, delayed psychological co-morbidities are not well studied to date. Therefore, the objective of the present study was to determine the prevalence of depressive, anxiety and stress symptoms among past dengue patients.Entities:
Keywords: Anxiety; Dengue; Depression; Psychiatry; Sri Lanka
Year: 2018 PMID: 29743940 PMCID: PMC5930431 DOI: 10.1186/s13033-018-0202-6
Source DB: PubMed Journal: Int J Ment Health Syst ISSN: 1752-4458
Socio-demographic data of the study and control group participants
| Variable | Category | Study group (n = 53) | Control group (n = 53) |
|---|---|---|---|
| Age | 18–35 years | 32% (17) | 37% (20) |
| 35–65 years | 57% (30) | 54% (28) | |
| > 65 years | 11% (06) | 9% (5) | |
| Gender | Female | 64% (34) | 64% (34) |
| Male | 36% (19) | 36% (19) | |
| Ethnicity | Sinhalese | 77% (41) | 70% (37) |
| Tamil | 8% (4) | 9% (5) | |
| Muslim | 9% (5) | 13% (7) | |
| Burgher | 6% (3) | 8% (4) | |
| Medical disorder | Diabetes mellitus | 11% (6) | 8% (4) |
| Hypertension | 6% (3) | 6% (3) | |
| Dyslipidaemia | 4% (2) | 6% (3) | |
| Hypothyroidism | 4% (2) | 4% (2) | |
| Ischaemic heart disease | 6% (3) | 4% (2) |
Data related to medical diagnosis and investigations of study group participants
| Variable | Category | Percentage (n = 53) |
|---|---|---|
| Diagnosis | Dengue fever | 91% (48) |
| Dengue haemorrhagic fever | 9% (5) | |
| Dengue shock syndrome | – | |
| Duration from diagnosis | Less than 12 months | 36% (19) |
| More than 12 months | 64% (34) | |
| Significant clinical features | High fever (> 40 °C) | 42% (22) |
| Altered level of consciousness | 2% (1) | |
| Loss of consciousness | 8% (4) | |
| Seizures | – | |
| Haematological parameters | Lowest platelet count mean value/µl (SD) | 61 (28) |
| Lowest white cell count mean/µl (SD) | 4862 (1593) | |
| Medical complications | Encephalopathy | 13% (7) |
| Respiratory failure | 2% (1) | |
| Liver failure | 2% (1) | |
| Cardiac failure | – | |
| Multi-organ failure | – |
Psychological symptom scores of the study and control group participants
| Assessment | Subscale | Study group mean (SD) | Control group mean (SD) | Significance |
|---|---|---|---|---|
| DASS-21 | Depressive | 11.7 (6.4) | 09.4 (4.0) | t = 2.2, p = .0287 |
| Anxiety | 10.7 (6.8) | 07.2 (1.8) | t = 3.6, p = .0005 | |
| Stress | 12.0 (5.3) | 08.8 (3.5) | t = 3.6, p = .0004 | |
| CESD-20 | Total | 16.1 (9.4) | 11.7 (7.3) | t = 2.6, p = .0083 |
Correlation of clinical parameters with psychological symptom scores of the study group participants
| Spearman’s correlation coefficient | DASS-21 Depressive score | DASS-21 | DASS-21 | DASS-21 | CESD-20 |
|---|---|---|---|---|---|
| Age in years | .186 | .035 | .092 | .142 | .138 |
| p value | .181 | .802 | .511 | .310 | .323 |
| Duration from diagnosis | .020 | .023 | .112 | .058 | -.089 |
| p value | .888 | .871 | .426 | .680 | .527 |
| Lowest platelet count | .350 | .142 | .140 | .268 | .286 |
| p value | .010 | .309 | .316 | .052 | .038 |
| Lowest white cell count | − .104 | .106 | − .077 | − .032 | − .129 |
| p value | .460 | .448 | .584 | .819 | .357 |